Gia L. Tyson
Research Subjects
Research Interests
Gia L. Tyson has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Andrew H. Talal
Division of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, University at Buffalo, State University of New York , Buffalo, New York
1 shared publication - Arpan Dharia
Division of Gastroenterology, Hepatology and Nutrition, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, 875 Ellicott Street, Suite 6090, Buffalo, NY 14203, USA
1 shared publication - Audrey R. Lloyd
Division of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham in Birmingham , Birmingham, Alabama
1 shared publication - Brandon Mizroch1 shared publication
- Christopher J. Gonzalez
Weill Cornell Medicine
1 shared publication - Donna Sullivan
Donna Sullivan, PharmD, MS, Washington State Health Care Authority, Olympia, USA
1 shared publication
Latest Publications
- Open Access
- 18 August 2023
- Published by Wolters Kluwer Health in Journal of Public Health Management & Practice
- Vol. 30 (2) , 208-212
Hepatitis C Virus Elimination Programs in Louisiana and Washington: Importance of Screening and Surveillance Systems
The US government has established a national goal of hepatitis C virus (HCV) elimination by 2030. To date, most HCV elimination planning and activity have been at the state level. Fifteen states presently have publicly available HCV elimination plans. In 2019, Louisiana and Washington were the first states to initiate 5-year funded HCV elimination programs. These states differ on motivation for pursuing HCV elimination and ranking on several indicators. Simultaneously, however, they have emphasized several similar elimination components including HCV screening promotion through public awareness, screening expansion, surveillance enhancement (including electronic reporting and task force development), and harm reduction. The 13 other states with published elimination plans have proposed the majority of the elements identified by Louisiana and Washington, but several have notable gaps. Louisiana's and Washington's comprehensive plans, funding approaches, and programs provide a useful framework that can move states and the nation toward HCV elimination.
- 18 August 2023
- Published by Wolters Kluwer Health in Journal of Public Health Management & Practice
- Vol. 30 (2) , 208-212
Open AccessHepatitis C Virus Elimination Programs in Louisiana and Washington: Importance of Screening and Surveillance Systems
The US government has established a national goal of hepatitis C virus (HCV) elimination by 2030. To date, most HCV elimination planning and activity have been at the state level. Fifteen states presently have publicly available HCV elimination plans. In 2019, Louisiana and Washington were the first states to initiate 5-year funded HCV elimination programs. These states differ on motivation for pursuing HCV elimination and ranking on several indicators. Simultaneously, however, they have emphasized several similar elimination components including HCV screening promotion through public awareness, screening expansion, surveillance enhancement (including electronic reporting and task force development), and harm reduction. The 13 other states with published elimination plans have proposed the majority of the elements identified by Louisiana and Washington, but several have notable gaps. Louisiana's and Washington's comprehensive plans, funding approaches, and programs provide a useful framework that can move states and the nation toward HCV elimination.